Does APREPITANT Cause Pulmonary fibrosis? 215 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Pulmonary fibrosis have been filed in association with APREPITANT (CINVANTI). This represents 3.8% of all adverse event reports for APREPITANT.
215
Reports of Pulmonary fibrosis with APREPITANT
3.8%
of all APREPITANT reports
207
Deaths
207
Hospitalizations
How Dangerous Is Pulmonary fibrosis From APREPITANT?
Of the 215 reports, 207 (96.3%) resulted in death, 207 (96.3%) required hospitalization, and 207 (96.3%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which APREPITANT Alternatives Have Lower Pulmonary fibrosis Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL